{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:26:57Z","timestamp":1787131617107,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["S202510316094"],"award-info":[{"award-number":["S202510316094"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0109800"],"award-info":[{"award-number":["2023YFE0109800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022 M723508"],"award-info":[{"award-number":["2022 M723508"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82204340"],"award-info":[{"award-number":["82204340"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472139"],"award-info":[{"award-number":["82472139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114698","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:04:52Z","timestamp":1770969892000},"page":"114698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunosuppressive-responsive hydrogel for self-regulated drug release and tumor microenvironment reprogramming"],"prefix":"10.1016","volume":"392","author":[{"given":"Yuxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114698_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0010","first-page":"419","article-title":"Dark side of cytotoxic therapy: Chemoradiation-induced cell death and tumor repopulation, trends","volume":"6","author":"Jiang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2026.114698_bb0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","article-title":"Repopulation of cancer cells during therapy: an important cause of treatment failure","volume":"5","author":"Kim","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114698_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114698_bb0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbi.2010.03.010","article-title":"Synergism between immunostimulation and prevention of surgery-induced immune suppression: An approach to reduce post-operative tumor progression","volume":"24","author":"Avraham","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jconrel.2026.114698_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7150\/thno.104872","article-title":"Metformin-based nanomedicines for reprogramming tumor immune microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114698_bb0035","article-title":"Dendritic nanomedicine with boronate bonds for augmented chemo-immunotherapy via synergistic modulation of tumor immune microenvironment","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41423-023-01123-9","article-title":"Inactivation of TGF-\u03b2 signaling in CAR-T cells","volume":"21","author":"Yang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","article-title":"TGF-\u03b2 regulation of T cells","volume":"41","author":"Chen","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0055","article-title":"The love-hate relationship between TGF-\u03b2 signaling and the immune system during development and tumorigenesis","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0060","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","article-title":"Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial","volume":"23","author":"Yamazaki","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202304328","article-title":"A hybrid Nanoadjuvant simultaneously depresses PD-L1\/TGF-\u03b21 and activates cGAS-STING pathway to overcome radio-immunotherapy resistance","volume":"36","author":"Yi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0070","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.immuni.2019.11.003","article-title":"PD-L1:CD80 cis-heterodimer triggers the co-stimulatory receptor CD28 while repressing the inhibitory PD-1 and CTLA-4 pathways","volume":"51","author":"Zhao","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114698_bb0075","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-2600(24)00185-1","volume":"12","author":"Shiraishi","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2026.114698_bb0080","article-title":"A tumor microenvironments-adapted polypeptide hydrogel\/Nanogel composite boosts antitumor molecularly targeted inhibition and Immunoactivation","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2021.06.012","article-title":"Simultaneous blockage of contextual TGF-\u03b2 by cyto-pharmaceuticals to suppress breast cancer metastasis","volume":"336","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114698_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.140830","article-title":"Programmed cyclodextrin-based core\u2013shell nanoparticles for cooperative TGF-\u03b2 blockade to reverse immunosuppression post photodynamic therapy","volume":"455","author":"Han","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114698_bb0095","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114698_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment","volume":"17","author":"Zhao","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70023","article-title":"Unlocking T-cell plasticity in the tumor microenvironment: implications for cancer progression and therapeutic strategies","volume":"4","author":"Ding","year":"2025","journal-title":"MedComm \u2013 Oncology"},{"key":"10.1016\/j.jconrel.2026.114698_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-020-00431-0","article-title":"Injectable hydrogels of newly designed brush biopolymers as sustained drug-delivery vehicle for melanoma treatment","volume":"6","author":"Shukla","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114698_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309667","article-title":"Promoting the recruitment, engagement, and reinvigoration of effector T cells via an injectable hydrogel with a supramolecular binding capability for Cancer immunotherapy","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103836","article-title":"Tumor-microenvironment-responsive nanomedicine for enhanced Cancer immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114698_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101003","article-title":"Tumor microenvironment-responsive hyperbranched polymers for controlled drug delivery","volume":"14","author":"Guo","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.114698_bb0130","first-page":"549","article-title":"Chemo-immunotherapy by dual-enzyme responsive peptide self-assembling abolish melanoma","volume":"31","author":"Wang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0135","article-title":"Localized microrobotic delivery of enzyme-responsive hydrogel-immobilized therapeutics to suppress triple-negative breast cancer","volume":"21","author":"Tian","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114698_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401537","article-title":"Intraoperative cavity local delivery system with NETs-specific drug release for post-breast cancer surgery recurrence correction","volume":"13","author":"Zhu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2020.100702","article-title":"Poly(N-isopropylacrylamide)-based smart hydrogels: design, properties and applications","volume":"115","author":"Tang","year":"2021","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.jconrel.2026.114698_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.carbpol.2017.05.086","article-title":"Cyclodextrin-based nanosponges: a critical review","volume":"173","author":"Sherje","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.114698_bb0155","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.7150\/thno.31913","article-title":"Integrating stimuli-responsive properties in host-guest supramolecular drug delivery systems","volume":"9","author":"Braegelman","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114698_bb0160","article-title":"Cucurbituril-based supramolecular polymers for biomedical applications","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114698_bb0165","doi-asserted-by":"crossref","first-page":"28665","DOI":"10.1021\/acsami.9b09059","article-title":"Host\u2013guest interactions initiated supramolecular chitosan nanogels for selective intracellular drug delivery","volume":"11","author":"Ding","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114698_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101139","article-title":"Polyamine-responsive morphological transformation of a supramolecular peptide for specific drug accumulation and retention in cancer cells","volume":"17","author":"Sun","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114698_bb0175","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1039\/C8CC09432B","article-title":"Dual stimuli-responsive bispillar[5]arene-based nanoparticles for precisely selective drug delivery in cancer cells","volume":"55","author":"Cheng","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.114698_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.actbio.2017.05.009","article-title":"Combined delivery of a TGF-\u03b2 inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy","volume":"61","author":"Jiang","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120429","article-title":"Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy","volume":"266","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114698_bb0190","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1021\/acsami.0c18545","article-title":"Hierarchically releasing bio-responsive nanoparticles for complete tumor microenvironment modulation via TGF-\u03b2 pathway inhibition and TAF reduction","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114698_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114698_bb0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1213\/ANE.0000000000001674","article-title":"A novel approach for the control of inflammatory pain: prostaglandin E2 complexation by randomly methylated \u03b2-Cyclodextrins","volume":"124","author":"Sauer","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2026.114698_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118954","article-title":"In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography","volume":"576","author":"Trencs\u00e9nyi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114698_bb0210","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1038\/s41467-025-60092-x","article-title":"Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling","volume":"16","author":"Peura","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114698_bb0215","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1038\/s41467-025-58220-8","article-title":"Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-\u03b2 and PGE2","volume":"16","author":"Sakref","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114698_bb0220","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s00262-023-03479-3","article-title":"TGF-\u03b21 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy","volume":"72","author":"Han","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.114698_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123116","article-title":"Inhibition of PDT-induced PGE2 surge for enhanced photo-immunotherapy","volume":"317","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114698_bb0230","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","article-title":"Nitric oxide signaling in health and disease","volume":"185","author":"Lundberg","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114698_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113750","article-title":"Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy","volume":"176","author":"Girotti","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13578-020-00431-1","article-title":"Interleukin-17 promotes nitric oxide-dependent expression of PD-L1 in mesenchymal stem cells","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.jconrel.2026.114698_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216931","article-title":"Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications","volume":"592","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114698_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconhyd.2018.02.002","article-title":"Spectroscopic methods for aqueous cyclodextrin inclusion complex binding measurement for 1,4-dioxane, chlorinated co-contaminants, and ozone","volume":"210","author":"Khan","year":"2018","journal-title":"J. Contam. Hydrol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202305557","article-title":"Rational design of dynamically super-tough and super-stretchable hydrogels for deformable energy storage devices","volume":"20","author":"Mo","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114698_bb0260","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1039\/D3FO00090G","article-title":"Preparation and characterization of an iron\u2013\u03b2-cyclodextrin inclusion complex: factors influencing the host\u2013guest interaction","volume":"14","author":"Saffarionpour","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2026.114698_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jddst.2018.03.004","article-title":"Cross-linked, cyclodextrin-based nanosponges for curcumin delivery - physicochemical characterization, drug release, stability and cytotoxicity","volume":"45","author":"Pushpalatha","year":"2018","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0270","article-title":"Glucose-activated programmed hydrogel with self-switchable enzyme-like activity for infected diabetic wound self-adaptive treatment","author":"Yang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0275","doi-asserted-by":"crossref","first-page":"eadd3197","DOI":"10.1126\/sciadv.add3197","article-title":"Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs","volume":"8","author":"Yang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114698_bb0280","doi-asserted-by":"crossref","first-page":"eabm3378","DOI":"10.1126\/sciadv.abm3378","article-title":"A thrombin-triggered self-regulating anticoagulant strategy combined with anti-inflammatory capacity for blood-contacting implants","volume":"8","author":"Wang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114698_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404904","article-title":"ZNF8 orchestrates with Smad3 to promote lung metastasis by recruiting SMYD3 in breast Cancer","volume":"11","author":"Geng","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114698_bb0290","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.apsb.2023.05.006","article-title":"Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-\u03b2-induced epithelial\u2013mesenchymal transition via directly targeting TGF\u03b2R1","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114698_bb0295","first-page":"969","article-title":"CD4+ T cells in antitumor immunity, trends","volume":"10","author":"Montauti","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2026.114698_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101150","article-title":"Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity","volume":"15","author":"Liu","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.114698_bb0305","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41563-018-0093-6","article-title":"Dendritic cells in cancer immunotherapy","volume":"17","author":"Le Gall","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.114698_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.009","article-title":"In situ repolarization of tumor-associated macrophages with synergic nanoformulation to reverse immunosuppressive TME in mouse breast cancer for cancer therapy","volume":"14","author":"Luo","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.114698_bb0315","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.114698_bb0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114698_bb0325","series-title":"Nitric Oxide Health Dis.","first-page":"135","article-title":"Chapter 5 - Cancer stem cells and nitric oxide","author":"Taskiran","year":"2023"},{"key":"10.1016\/j.jconrel.2026.114698_bb0330","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/pharmrev.121.000500","article-title":"Opportunities for nitric oxide in potentiating Cancer immunotherapy","volume":"74","author":"Kim","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2026.114698_bb0335","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1038\/s41467-024-54651-x","article-title":"NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression","volume":"15","author":"Reddy","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114698_bb0340","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-22-2791","article-title":"Targeting nitric oxide: say NO to metastasis","volume":"29","author":"Reddy","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114698_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216330","article-title":"Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGF\u03b2-dependent squamous cell carcinoma lung metastasis","volume":"570","author":"Li","year":"2023","journal-title":"Cancer Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:44:27Z","timestamp":1787129067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"alternative-id":["S0168365926001008"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114698","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive-responsive hydrogel for self-regulated drug release and tumor microenvironment reprogramming","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114698"}}